These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14588111)

  • 1. Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson E; Nicoll JA
    J Neurotrauma; 2003 Oct; 20(10):943-52. PubMed ID: 14588111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage.
    Kay A; Petzold A; Kerr M; Keir G; Thompson E; Nicoll J
    Stroke; 2003 Dec; 34(12):e240-3. PubMed ID: 14605321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury.
    Kay AD; Petzold A; Kerr M; Keir G; Thompson EJ; Nicoll JA
    J Neurotrauma; 2003 Mar; 20(3):243-50. PubMed ID: 12820678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of cerebrospinal fluid lipoprotein particles after human traumatic brain injury.
    Kay AD; Day SP; Kerr M; Nicoll JA; Packard CJ; Caslake MJ
    J Neurotrauma; 2003 Aug; 20(8):717-23. PubMed ID: 12965051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury.
    Franz G; Beer R; Kampfl A; Engelhardt K; Schmutzhard E; Ulmer H; Deisenhammer F
    Neurology; 2003 May; 60(9):1457-61. PubMed ID: 12743231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
    Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
    Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of β-amyloid oligomers as a predictor of neurological outcome after brain injury.
    Gatson JW; Warren V; Abdelfattah K; Wolf S; Hynan LS; Moore C; Diaz-Arrastia R; Minei JP; Madden C; Wigginton JG
    J Neurosurg; 2013 Jun; 118(6):1336-42. PubMed ID: 23540266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury.
    Emmerling MR; Morganti-Kossmann MC; Kossmann T; Stahel PF; Watson MD; Evans LM; Mehta PD; Spiegel K; Kuo YM; Roher AE; Raby CA
    Ann N Y Acad Sci; 2000 Apr; 903():118-22. PubMed ID: 10818496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
    Olsson A; Csajbok L; Ost M; Höglund K; Nylén K; Rosengren L; Nellgård B; Blennow K
    J Neurol; 2004 Jul; 251(7):870-6. PubMed ID: 15258792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome.
    Kay A; Petzold A; Kerr M; Keir G; Thompson E; Nicoll J
    Stroke; 2003 Mar; 34(3):637-42. PubMed ID: 12624284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers.
    Neselius S; Zetterberg H; Blennow K; Marcusson J; Brisby H
    PLoS One; 2013; 8(11):e81249. PubMed ID: 24260563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
    Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
    Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures.
    Shahim P; Rejdak R; Ksiazek P; Blennow K; Zetterberg H; Mattsson N; Rejdak K
    Eur J Neurol; 2014 Mar; 21(3):486-91. PubMed ID: 24372994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.
    Peskind ER; Li G; Shofer J; Quinn JF; Kaye JA; Clark CM; Farlow MR; DeCarli C; Raskind MA; Schellenberg GD; Lee VM; Galasko DR
    Arch Neurol; 2006 Jul; 63(7):936-9. PubMed ID: 16831961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injury.
    Mondello S; Buki A; Barzo P; Randall J; Provuncher G; Hanlon D; Wilson D; Kobeissy F; Jeromin A
    Sci Rep; 2014 Oct; 4():6446. PubMed ID: 25300247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of cerebrospinal fluid amyloid-β and tau levels in patients with prolonged posttraumatic disorders of consciousness.
    Bagnato S; Andriolo M; Boccagni C; Sant'Angelo A; D'Ippolito ME; Galardi G
    Brain Inj; 2018; 32(8):1056-1060. PubMed ID: 29792528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.
    Piazza F; Greenberg SM; Savoiardo M; Gardinetti M; Chiapparini L; Raicher I; Nitrini R; Sakaguchi H; Brioschi M; Billo G; Colombo A; Lanzani F; Piscosquito G; Carriero MR; Giaccone G; Tagliavini F; Ferrarese C; DiFrancesco JC
    Ann Neurol; 2013 Apr; 73(4):449-58. PubMed ID: 23625526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
    Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
    Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.
    Fortea J; Vilaplana E; Alcolea D; Carmona-Iragui M; Sánchez-Saudinos MB; Sala I; Antón-Aguirre S; González S; Medrano S; Pegueroles J; Morenas E; Clarimón J; Blesa R; Lleó A;
    Ann Neurol; 2014 Aug; 76(2):223-30. PubMed ID: 24852682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.